Skip to Main Content

Vor Biopharma Inc. Common Stock

VOR Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of VOR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
VOR Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
VOR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
VOR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by VOR's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

VOR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
VOR Income Statement
VOR Balance Sheet
VOR Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Mar. 18, 2025
  • Patent Title: Anti-cd45 antibodies and conjugates thereof Jan. 28, 2025
  • Patent Title: Compositions and methods for inhibition of lineage specific proteins May. 07, 2024
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Feb. 20, 2024
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Feb. 07, 2023
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Jan. 24, 2023
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Oct. 11, 2022
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Jul. 19, 2022
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Jul. 12, 2022
  • Patent Title: Genetically engineered hematopoietic stem cells and uses thereof Feb. 23, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
VOR News

Recent insights relating to VOR

WallStreetBets

Number of mentions of VOR in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for VOR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VOR

VOR Analyst Ratings

VOR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
VOR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $VOR stock a Buy, Sell, or Hold?

  • What is the price target for $VOR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

VOR Top Shareholders
Shareholder
Shares Held
VOR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $VOR stock?

  • Who owns the most shares of $VOR stock?

  • What funds own $VOR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

VOR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view VOR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top